Document:

Filed by sedaredgar.com - MabCure, Inc. - Exhibit 10.10

Exhibit 10.10 

DIRECTOR AGREEMENT 

          THIS
DIRECTOR AGREEMENT, (“Agreement”), is entered into this
17th day of April 2009 (the “Effective Date”), by and between
MabCure, Inc., a Nevada corporation (“MabCure"), and David S.
Frank, as Managing Director of MEDx Associates LLC, a New Jersey Limited
Liability Company (the "Director"). 

          WHEREAS,
the Director represents that he is ready, willing, and able to be a member of
the Board of Directors of MabCure; and

          WHEREAS,
the Board of Directors of MabCure wishes to appoint the Director to the Board of
Directors to fulfill a vacancy on the current Board of Directors in accordance
with the terms and conditions set forth herein;

          NOW,
THEREFORE, in consideration of the mutual promises hereinafter
contained, the Parties hereto agree as follows: 

1.       Scope of Services

          1.1     
The Director shall act as a member of the Board of Directors by participating in
up to 4 meetings of the Board of Directors each year and providing all services
pertaining to such meetings as requested of the Directors by MabCure and
required pursuant to the Bylaws of the Company and the laws of Nevada (the
"Services"). 

          1.2      Director
shall perform additional services as mutually agreed and in accordance with the
instructions of the Board of Directors pari passu with other directors of
MabCure.

2.       Consideration for
Services. 

          2.1      Annual
Compensation; Grant of Options. As annual compensation for your services
rendered as a Director, MabCure shall pay the Director an aggregate annual
compensation of US$4,000 payable in arrears in four equal quarterly installments
of $1,000 each, subject to deductions required to be made by MabCure under all
applicable laws. In the event that the MabCure Board of Directors shall
establish committees of the Board of Directors, and you become a member of such
a committee, an additional annual payment of $8,000 shall be made for your
services on one or more committees of the Board of Directors. As consideration
for the provision of the Services, MabCure shall grant you as a Director,
120,000 options to purchase 120,000 shares of common stock of MabCure, at an
exercise price of $1.00, the fair market value of such shares as of the date of
this Agreement (the “Options”). Subject to the approval of the MabCure stock
option plan, the Options shall be granted to the Director pursuant to the plan.
The Options shall vest pursuant to the vesting schedule attached as Exhibit
A. The Options shall be exercisable until the Expiration Date set forth in
Exhibit A in numbers of whole shares.

          2.2      Expenses.
MabCure shall reimburse Director for all pre-approved or post-approved,
reasonable, and actual expenses incurred by the Director in the course of the
Director's provision of the Services in accordance with this Agreement,
including reasonable travel expenses, incurred by Director in the performance of
the Services. 

3.       Confidential Information

          3.1     
Each party acknowledges that in connection with its duties hereunder it may be
provided with or have access to written information data and/or other
confidential material ("the Information") which is proprietary and/or
confidential to the other party, and which is so marked proprietary and/or
confidential or which it would be reasonable to assume was proprietary or
confidential due to the nature of the Information disclosed. Both parties agree
to keep confidential all such Information and shall not disclose the same either
in whole or in part to any third party without the other party's prior written
consent. Information which is already in the public domain or which is known to
the receiving party without a breach of this or any other Agreement or any other
obligation of confidentiality shall not be treated as confidential for the
purposes of this Agreement. 

          3.2     
Upon termination of this Agreement, the Director shall (a) immediately cease
using the Information, (b) promptly return to MabCure all tangible embodiments
of the Information, and (c) promptly certify in writing the Director's
compliance with this obligation. Notwithstanding the foregoing, Counsel for the
Director may retain one copy of MabCure’s Information solely for archival
purposes. 

          3.3     
In the event that a party breaches a provision of this Section 3, the damage to
the other party may be irreparable. Therefore, in the event of a breach or
threat of breach, the owner of the Information shall be entitled to request
equitable relief to restrain such breach or threat of breach, in addition to any
other relief available at law or in equity. 

          3.4      As
additional protection for MabCure’s Information, the Director agrees that during
the period over which it is to be providing Services and for one year
thereafter, the Director (a) will not encourage or solicit any employee or
Director of MabCure to leave MabCure for any reason, (b) will not engage in any
activity that is in any way competitive with the business or demonstrably
anticipated business of MabCure, and (c) will not assist any other person or
organization in competing or in preparing to compete with any business or
demonstrably anticipated business of MabCure.

          3.5     
For purposes of clarification, MabCure acknowledges that the Director may
provide consulting services to other companies in the field of antibody
detection. In such a case, however, the Director commits to disclose to MabCure
the general nature of the services being provided and to ensure that (a)
MabCure’s Information is not 

2 

disclosed to the other entity, (b) that the other entity's
confidential information is not disclosed to MabCure, and (c) the Director does
not have a conflict of interest. 

4.       Intellectual Property
  Rights

          4.1      All
  right, title, and interest in and to all deliverables, and any discovery, invention,
  improvement, patent, works of authorship, or other proprietary technical and
  programming data conceived, discovered, or developed by the Director in the
  course of the performance of the Services (the “Discoveries”), including
  all rights in copyrights or other intellectual property rights pertaining to
  the deliverables or the Discoveries shall belong exclusively to MabCure. All
  deliverables and Discoveries shall, to the extent possible, be considered works
  made by the Director for hire for the benefit of MabCure. In the event that
  the deliverables or Discoveries cannot constitute work made by the Director
  for hire for the benefit of MabCure under applicable law, or in the event that
  the Director should otherwise retain any rights to any deliverables or Discoveries,
  the Director agrees to assign, and upon creation thereof automatically assigns,
  all right, title, and interest in and to such deliverables and Discoveries to
  MabCure, without further consideration. The Director agrees to execute any documents
  of assignment or registration of copyright or patents requested by MabCure respecting
  any and all deliverables and Discoveries. 

          4.2     
The Director, in developing materials and carrying out consultancy work for
third parties, shall not utilize or copy in whole or in part any original
material whether written or readable by machine or otherwise developed for
MabCure under this Agreement. 

5.       Warranties.

          Director
warrants that: (a) the Services will be performed in a professional manner; (b)
none of the Services or any part of this Agreement is or will be inconsistent
with any obligation Director may have to others; (c) none of the Services will
infringe, misappropriate or violate any intellectual property or other right of
any person or entity; and, (d) Director has the full right to allow it to
provide MabCure with the assignments and rights provided for herein.

6.       Term and
Termination.

          6.1      This
Agreement shall be effective as of the Effective Date and shall continue in
effect unless terminated earlier pursuant to the terms of this Agreement. 

          6.2      This
Agreement may be terminated by either Party for conveneince upon advance written
notice of thirty (30) days.

          6.3     
Upon termination of this Agreement for any reason, the Director shall promptly
return to MabCure all copies of any MabCure data, records, or materials of 

3 

whatever nature or kind, including all materials incorporating
the proprietary information of MabCure.

7.       Relationship of the
Parties. 

          Notwithstanding
any provision hereof, Director is an independent contractor and not an employee
or agent of MabCure, and shall not bind nor attempt to bind MabCure to any
contract. Director shall accept any directions issued by MabCure pertaining to
the goals to be attained and the results to be achieved but shall be solely
responsible for the manner and hours in which Services are performed under this
Agreement. Director shall not be eligible to participate in any of MabCure’s
employee benefit plans, fringe benefit programs, group insurance arrangements or
similar programs. MabCure shall not provide workers’ compensation, disability
insurance, Social Security or unemployment compensation coverage or any other
statutory benefit to Director.

8.       Limitation of
Liability; Indemnification 

          8.1     
Limitation of Liability. Neither party shall be liable hereunder for any
indirect, special, or consequential losses or damages of any kind or nature
whatsoever, including but not limited to lost profits, regardless of whether
arising from breach of contract, warranty, tort, strict liability or otherwise,
even if advised of the possibility of such loss or damage, or if such loss or
damage could have been reasonably foreseen. 

          8.2      Indemnification.
MabCure shall indemnify the Director to the fullest extent permitted by Nevada
law in connection with any action, suit, or proceeding brought against the
Director or threatened to be brought against the Director by reason of him being
a Director of MabCure, in accordance with the indemnification procedures set
forth in Article 11 of MabCure's Articles of Incorporation. In addition, the
Director shall be covered by any "director and officer" insurance policy held by
MabCure on the same basis as other directors. 

9.       Miscellaneous 

          9.1     
Assignment. This Agreement and the services contemplated hereunder are
personal to Director and Director shall not have the right or ability to assign,
transfer, or subcontract any obligations under this Agreement without the
written consent of MabCure. Any attempt to do so shall be void.

          9.2     
Notices. All notices under this Agreement shall be in writing, and shall
be deemed given when personally delivered, or three days after being sent by
prepaid certified or registered mail to the address of the party to be noticed
as set forth herein or such other address as such party last provided to the
other by written notice. 

          9.3     
No Waiver. The failure of either party to enforce its rights under this
Agreement at any time for any period shall not be construed as a waiver of such
rights.

4 

          9.4      Modifications.
No changes or modifications or waivers to this Agreement will be effective
unless in writing and signed by both parties.

          9.5     
Severability. In the event that any provision of this Agreement shall be
determined to be illegal or unenforceable, that provision will be limited or
eliminated to the minimum extent necessary so that this Agreement shall
otherwise remain in full force and effect and enforceable.

          9.6     
Governing Law. This Agreement shall be governed by and construed in
accordance with the laws of the State of New York without regard to the
conflicts of laws provisions thereof. Any dispute arising from or in connection
with this Agreement shall be submitted to binding arbitration to take place in
New York pursuant to the rules and regulations of the American Arbitration
Association.

          9.7     
Headings. Headings herein are for convenience of reference only and shall
in no way affect interpretation of the Agreement. 

          IN
WITNESS WHEREOF, the parties have executed this Agreement as of the Effective
Date first above written. 

	MabCure, Inc. 	David S. Frank 
	  	  
	/s/ Amnon Gonenne 	/s/ David S. Frank 
	  	  
	By: Amnon Gonenne 	By: David S. Frank 
	Title: President & CEO 	Title: Managing Director, MEDx Associates LLC
    
	Date: April 17, 2009 	Date: April 17, 2009 

5 

EXHIBIT A 

VESTING SCHEDULE 

	Option Holder: 	David S Frank 	 
	  	 	 
	Date of Grant: 	________ , 2009 	 
	  	 	 
	Vesting 	________, 2009 	 
	Commencement 	 	 
	Date: 	 	 
	  	 	 
	Option Price per 	$ 1.00 	 
	Share (Exercise 	 	 
	Price): 	 	 
	  	 	 
	Total Number of 	 	 
	Shares Subject to the 	 	 
	Options: 	120,000 Shares 	 
	  	 	 
	Expiration Date: 	________, 2014 	 
	  	 	 
	Type of 	Incentive Stock
      Option                  
       Non-Qualified Stock Option 	 
	Option: 	 	 
	  	 	 
	
      Vesting Schedule: 
	
      All of the Options shall fully vest on March _, 2010, the
      first anniversary of the Vesting Commencement Date, provided that Mr.
      Frank continues to be a Director of MabCure through the first anniversary
      of the Vesting Commencement Date. 
	

 

	MABCURE, INC. 	 	 David S. Frank 
	 	 	 	 	 
	By: 	/s/
      Amnon Gonenne 	 	By: 	/s/
      David S. Frank 
	 	 	 	 	 
	Name: 	Amnon
      Gonenne 	 	Name: 	David
      S. Frank 
	 	 	 	 	 
	Title: 	CEO 	 	Title: 	Managing Director, MEDx 
	  	  	 	  	Associates LLC 

6innerlights1a7ex10-11.htm

    
      

      

    

    Exhibit 10-11

     

    Exhibit
1.06(a)(vi)(A)

     CONSULTING
AGREEMENT

     

    THIS
CONSULTING AGREEMENT (this "Agreement") is made effective the 15th day of
January, 2001, by and between DARIUS MARKETING INC. (hereinafter referred to as
the "Company"), and ROBERT O. YOUNG ("Robert") and SHELLEY R. YOUNG ("Shelley";
Robert and Shelley shall hereinafter be referred to collectively as the
"Consultants").

     

     

    EXPLANATORY
STATEMENT

     

    The
Company has purchased the business and certain of the assets of HIKARI HOLDINGS,
LC. and INNERLIGHT INTERNATIONAL, INC. (the "Sellers") under that certain Asset
Purchase Agreement dated January 15, 2001, by and among various parties
including the Company and the Consultants (the "Acquisition
Agreement").

     

    For many
years, the Consultants have been key employees and principal owners of the
Sellers, and possess valuable knowledge, expertise and experience in the
business of developing, marketing and selling nutritional supplements, dietary
supplements and related products (the "Products" as defined below in Section
3.3); such Products are distributed for sale through independent representatives
nationally and internationally (collectively, the "Business"). The Company
believes that the Consultants' knowledge, expertise and experience would benefit
the Company, and the Company desires to retain the Consultants to perform
certain consulting services for the Company. The Company further desires to
insure that the Consultants do not compete with the Company, and its affiliates,
except as expressly permitted hereby.

     

    NOW,
THEREFORE, in consideration of their mutual agreements and covenants contained
herein, and for other valuable consideration, the receipt and sufficiency of
which is hereby acknowledged, and in further consideration of the affixation by
the parties of their respective seals herein below, the parties agree as
follows:

     

               1.        Consulting
Services.

     

                          1.1.    Duties; Services. The
Consultants agree that, for a period of two (2) years beginning on the date of
this Agreement (which then shall renew automatically from year to year unless
sooner terminated by the Company in accordance with the terms of this
Agreement):

     

                                    1.1.1.
The Consultants will perform certain consulting services for the Company, and
will be reasonably available for approximately ten (10) hours per month and at
ten (10) events per year to advise, counsel and inform designated officers and
employees of the Company about the industry, business, customers, budgeting,
expenses, marketing and other aspects of or concerning the Company's business
about which the Consultants have knowledge or expertise.

     

    

    
      
        
           

        

        
           

          
            

          

        

        
           

        

      

    

     

                                    1.1.2.
The Consultants shall serve as independent representatives of the Company and
shall assist and advise the Company in developing new representatives, Company
products and/or services and implementing Company programs. During the term of
the consulting engagement under this Agreement, the Consultants shall use the
best efforts of the Consultants to further the network marketing operations
of the Company and the Consultants shall be available, at such times and places
for approximately ten (10) hours per month and at ten (10) events per year, as
reasonably requested by the Company and agreed to by the Consultants to meet
with, assist, advise and otherwise work with and for the Company and its
responsible personnel with regard to: (i) advice on the proper and efficient
conduct of the business of the Company and utilization of employees of the
Company; (ii) future business activities of the Company as to which the
Consultants may have or acquire knowledge; (iii) customer relationships and
activities; and (iv) the development of business opportunities and any other
matters which the parties may hereafter reasonably agree upon. It is
specifically understood that the Consultants have complete discretion and
control as to how their duties under this Agreement shall be discharged. The
Consultants shall generally be under the supervision of and shall report to the
President and Chief Executive Officer of the Company and of Darius International
Inc.

     

     

                          1.2.
Independent
Contractors. The Consultants shall render services to the Company as
independent contractors, and not as employees. The Consultants, rather than the
Company, shall have ultimate control over the scope and details of the
Consultants' activities pursuant to this Agreement; however, all services
rendered by the Consultants on behalf of the Company shall be performed to the
best of the Consultants' ability. As independent contractors:

     

                                    1.2.1.
The Consultants shall be responsible and liable for the payment of any and all
federal, state and local taxes payable by reason of the Consultants' receipt of
compensation under this Agreement and for any and all taxes, contributions or
other sums payable for unemployment compensation insurance and old age
retirement benefits. The Consultants agree to indemnify and hold harmless the
Company from and against any and all liabilities, obligations, costs and
expenses, including attorney's fees, resulting from any claim asserted against
the Company with respect to the withholding, reporting or payment of employment
or income taxes in connection with compensation or amounts payable to the
Consultants under this Agreement.

     

                                    1.2.2.
The Consultants shall not be entitled to participate in or receive any fringe or
retirement benefits, including medical, dental, life insurance, disability
insurance or retirement benefits, which the Company or its Affiliates (defined
below) may provide to its employees from time to time.

     

                                    1.2.3.
The Consultants shall be responsible for providing worker's compensation and
liability insurance coverage for the Consultants and any agents or employees he
or she retains and shall be responsible for any and all claims, damages and
suits resulting from the negligence or improper performance of obligations by
the Consultants or any agents or employees of the Consultants.

     

                                    1.2.4.
The Consultants shall have' no right or authority at any time to make any
contract or binding promise of any nature on behalf of the Company, either oral
or written, without the express written consent of an authorized representative
of the Company.

     

                          1.3.
Termination.
The Consultants' engagement hereunder may be terminated immediately by the
Company for Cause upon written notice to the Consultants. The term "for Cause"
for the purposes of this Agreement shall mean any (a) breach or violation of the
terms and conditions of this Agreement by the Consultants; (b) willful disregard
of or failure to perform duties or obligations under this Agreement; (c)
habitual absence from engagement hereunder except that caused by sickness; (d)
drunkenness or drug abuse; (e) dishonesty; (0 selling, passing, or otherwise
using without permission any confidential information of the Company; (g) action
or engagement in competition of the Company; or (g) a Consultant's physical or
mental injury, illness, disability, or incapacity, such that the Consultant is
unable to render the consulting services provided for in this Agreement for
a consecutive period of ninety (90) days.

     

    

    
      
        
           

        

        
          - 2
-

          
            

          

        

        
           

        

      

    

     

               2.        Non-Competition and
Confidentiality Covenants.

     

                          2.1.
The Consultants shall not, for so long as the Company pays the Consultants a
monthly payment pursuant to the terms of this Agreement (reduced, as applicable,
subject to Section 3.6) (the "Non-Competition Period"), without the Company's
prior and specific written consent, engage in any of the following
activities:

     

                                    2.1.1.
Directly or indirectly, anywhere in the world, as a principal, partner,
shareholder, agent, director, employee, consultant, or in any other capacity
whatsoever, engage, participate, invest or become interested in, affiliated or
connected with, render services to, or, in exchange for any compensation or
remuneration, direct or indirect, furnish any aid, assistance or advice to any
person, corporation, firm or other organization engaged in, a business that
is competitive with the Business that is conducted by the Company, or by any
Affiliate, as defined in Section 2.3, as of the date hereof or to be conducted
by the Company, or by any Affiliate, immediately after the date hereof with the
assets acquired pursuant to the Acquisition Agreement.

     

                                    2.1.2.
Directly or indirectly, as a principal, partner, shareholder, agent, director,
employee, consultant, or in any other capacity whatsoever, employ, retain, or
enter into any employment, agency, consulting or other similar arrangement with,
any person who, within the twelve-month period prior to such employment,
retention or arrangement, was an employee of the Company, or of any Affiliate,
or, induce or attempt to induce any employee of the Company, or of any
Affiliate, to terminate his employment with the Company, or with any
Affiliate.

     

                          2.2.
The Consultants acknowledge that it is the policy of the Company to maintain as
secret and confidential all Confidential Information as hereinafter
defined.

     

                                    2.2.1.
"Confidential Information" shall mean any information, not generally known in
the Company's industry, which information was either sold by the Consultants or
the Sellers to the Company or acquired by Consultants from the Company, and
which gives the Company a competitive advantage in the industry, heretofore or
hereafter acquired, discovered, developed, conceived, originated, used or
prepared by the Company or by an employee of the Company as the result of
employment with the Company and which falls within the following
categories:

     

                                               (a)
Information relating to trade secrets of the Company or any supplier, customer,
distributor, independent representative or consultant of the
Company;

    

                                               (b)
Information relating to existing or contemplated products of the Company,
services, technology, designs, processes, manuals, formulas, computer systems
and/or software, and any research or development of the Company or any supplier
or customer of the Company;

    

    
      
        
           

        

        
          - 3
-

          
            

          

        

        
           

        

      

    

    

                                               (c)
Information relating to business plans, sales or marketing methods, methods of
doing business, distributor or independent representative lists or information,
customer lists, customer usages and/or requirements, and supplier or customer
information of the Company or any supplier or customer of the
Company;

    

                                               (d)
Information relating to work product in general; and

     

                                               (e)
Any other confidential information that either the Company or any supplier,
distributor, independent representative or consultant customer of the Company
may wish to protect by patent, copyright or by keeping it secret and
confidential.

     

                                    2.2.2
The Consultants recognize that the services to be performed by the Consultants
are special and unique, and that by reason of their duties, they will acquire
Confidential Information. The Consultants recognize that all such Confidential
Information is the property of the Company. In consideration of the Company's
entering into this Agreement, the Consultants agree that:

     

                                               (a)
The Consultants shall never, during the term of engagement or thereafter,
directly or indirectly, use, publish, disseminate or otherwise disclose any
Confidential Information obtained in connection with their engagement by the
Company without the prior written consent of the Company;

     

                                               (b)
During the term of their engagement by the Company, the Consultants shall
exercise all due and diligent precautions to protect the integrity of the
Company's Confidential Information and, upon termination of their engagement,
the Consultants shall return ail documents containing any Confidential
Information and any copies thereof, in their possession or control;
and

     

                                               (c)
During the Non-Competition Period, the Consultants shall exercise all due and
diligent precautions to protect any Confidential Information and shall never,
directly or indirectly, use, publish, disseminate or otherwise disclose any
Confidential Information obtained in connection with their
engagement.

     

                                    2.2.3.
Upon termination or expiration of this Agreement, the Consultants shall
immediately deliver to the Company all books, records, memoranda, reports,
software data and documents relating to the Company's business, suppliers,
customers and other assets of the Company in the possession, custody or under
the control of the Consultants, whether or not such material contains
Confidential Information. .

     

                          2.3.
The Consultants and the Company acknowledge and agree that (i) the restrictions
set forth in this Section 2 are reasonable in terms of scope, duration,
geographic area, and otherwise, and (ii) the protections afforded to the
Company, and its Affiliates, hereunder are necessary to protect their legitimate
business interests.

     

                          2.4.
For the purposes hereof, the term "Affiliate" shall mean any corporation,
partnership or other firm or entity that is engaged in the Business, and
(i) that owns more than 50% of the stock of the Company, or (ii) more than 50%
of the ownership interests of which are owned by the Company or by stockholders
of the Company, including, without limitation, Darius International
Inc.

    

    
      
        
           

        

        
          - 4
-

          
            

          

        

        
           

        

      

    

     

               3.        Compensation.

     

                          3.1.
Allocation;
Term. In consideration of the Consultants' covenants hereunder, the
Consultants shall be entitled to payment of the consideration described in
Section 3.2. The consideration shall be allocated (a) Fifty Percent (50%) as
compensation for consulting services, and (b) Fifty Percent (50%) as
compensation for Consultants' restrictive covenants. Unless sooner terminated
pursuant to Section 1.3 or Sections 3.4 and 3.5 hereof, this Agreement shall
terminate upon the later to occur of Robert's or Shelley's death, provided that
the Company shall continue to make payments to the estate of the second to die
of Robert or Shelley until the "Minimum Payment" (defined below) has been paid
to the Consultants or their estates. The "Minimum Payment” shall be Five Hundred
Forty Thousand Dollars ($540,000), as reduced (if at all) pursuant to Section
3.6 hereof.

     

                                    3.1.1.
Except for a sale, reorganization, assignment or other transaction upon which
the successor company shall assume all of the Company's obligations under this
Agreement, for so long as payments of the Minimum Payment are being made by the
Company to the Consultants pursuant to this Agreement, the Company agrees that
it will not transfer the Purchased Assets (as defined in the Acquisition
Agreement), Products, and/or the Business to another company in a manner which
would alter or jeopardize the Business, the Adjusted Gross Revenues and/or
intended payment obligations as set forth in this Agreement or the Acquisition
Agreement.

     

                          3.2.
Consideration.
Subject to Section 3.6 hereof, the consideration payable to the Consultants
under this Agreement shall be payable on the fifteenth (15th) day of
each month beginning March 15, 2001 (each, a "Payment Date"), as
follows:

     

                                    3.2.1.
Until such time as payments to the Consultants under this Section 3.2 aggregate
the Minimum Payment, Consultants shall be entitled to receive:

     

                                               (a)
Twelve Percent (12%) of "Adjusted Gross Revenues" (defined below) for the month
preceding the Payment Date, if during such month Adjusted Gross Revenues were
not less than Two Hundred Fifty Thousand Dollars ($250,000); OR

     

                                               (b)
Ten Percent (10%) of Adjusted Gross Revenues for the month preceding the Payment
Date, if during such month Adjusted Gross Revenues were less than Two Hundred
Fifty Thousand Dollars ($250,000).

     

                                    3.2.2.
For all Payment Dates after payments to the Consultants under this Section 3.2
aggregate the Minimum Payment, Consultants shall be entitled to receive Five
Percent (5%) of Adjusted Gross Revenues for the month preceding the Payment
Date.

     

                          3.3.
Adjusted Gross
Revenues. For the purposes hereof, "Adjusted Gross Revenues" shall mean
the Company's revenues (determined in accordance with generally accepted
accounting principles of the United States) attributable to sales of the
Products, adjusted for returns, allowances and discounts. "Products"
means those nutrition, dietary supplements and related products (the "Products")
which were purchased by the Company from the Sellers and are listed on Exhibit A to the Acquisition
Agreement, together with any additional products purchased by the Company from
Sellers and/or Consultants pursuant to Section 1.09 of the Acquisition
Agreement. Consultants shall have the rights to (i) request and receive periodic
reports of Adjusted Gross Revenues from the Company, and (ii) at Consultants'
expense, to audit (no less frequently than annually) the Company's books and
records relating to the Business, in each case to verify the Company's
calculation of Adjusted Gross Revenues and payment of the consideration
hereunder.

    

    
      
        
           

        

        
          - 5
-

          
            

          

        

        
           

        

      

    

     

                          3.4.
Decline in Adjusted
Gross Revenues. With respect to any year beginning))n or after January 1,
2003, in the event that Adjusted Gross Revenues are less than Three
Milli0rt/F1ve Hundred Thousand Dollars ($3,500,000), or the Company ceases sales
of the Products, the Company may elect either (a) with respect to each such year
(a "Payment Year'), continue to pay the Consultants Five Percent (5%) of
Adjusted Gross Revenues in the manner set forth above, provided that if, after
all payments with respect to such Payment Year have been made, the Consultants
have not received an aggregate of One Hundred Seventy Five Thousand Dollars
($175,000) in payments, the Company shall pay the Consultants the amount of such
shortfall not later than January 31 of the following year, or (b) to terminate
this Agreement, in which case the provisions of Section 3.5 shall
apply.

     

                          3.5.
Termination. In
the event the Company elects to terminate this Agreement in accordance with
Section 3.4, (a) the Company shall grant to the Consultants anon-exclusive,
non-assignable license to market the Products, either personally or through the
Sellers, under a private label (but without any rights to the "Trademarks"
referenced in the Acquisition Agreement), (b) if the Company has terminated this
Agreement prior to the payment of the Minimum Payment, the Company shall forfeit
and terminate the license set forth in Section 1.11 of the Acquisition
Agreement, and shall be required to discontinue use of the ingredients and
formulas, and (c) the Sellers' restrictive covenants in Section 6.03 of the
Acquisition Agreement, and the Consultants' restrictive covenants contained
herein and in a Non-Competition Agreement of even date herewith, shall, if not
already expired, terminate,

     

                          3.6.
Reduction of
Compensation. The compensation payable to the Consultants hereunder shall
be Subject to reduction as provided in Section 6 of this Agreement and in
Section 6.01(d) of the Acquisition Agreement.

     

                          3.7.
Guaranty. The
Company's obligation to make payments to the Consultants has been guaranteed by
Darius International Inc. pursuant to the Guaranty Agreement executed
simultaneously herewith.

     

                          3.8.
Reimbursement of
Expenses. The Company shall reimburse the Consultants for all expenses
incurred in connection with their duties on behalf of the Company and
pre-approved by the Company, provided that such expenses shall, in all cases, be
subject to the Company's policies in effect from time to time, and the
Consultants shall keep, and present to the Company, records and receipts
relating to reimbursable expenses incurred by them. Such records and receipts
shall be maintained and presented in a format, and with such regularity, as the
Company reasonably may require in order to substantiate the Company's right to
claim income tax deductions for such expenses.

    

    
      
        
           

        

        
          - 6
-

          
            

          

        

        
           

        

      

    

     

               4.       
Prior
Restriction.  The Consultants represent and covenant to the
Company that (a) the Consultants are able in all respects to execute and perform
this Agreement, and the execution and performance hereof does not constitute a
breach or default under any other agreement, contract or arrangement which is
binding upon the Consultants; (b) the Consultants are entering into this
Agreement in good faith, are free to execute this Agreement and to enter into
the engagement pursuant to the provisions hereof; (c) the Consultants are not
presently engaged and shall not during the term of this Agreement be engaged in
any enterprise and are not receiving income or royalties from any company
engaged in the Business; and (d) the Consultants shall disclose the existence
and terms of the restrictive covenants set forth in this Agreement to any
employer or entity that the Consultants may work for during the term of this
Agreement or after the termination of the Consultants' engagement with the
Company.

     

               5.        Assignment. This
Agreement is personal to the Consultants and may not be assigned in any way by
them except as may be agreed to in writing by the Company. If at any time during
the term of this Agreement, the Company shall merge or consolidate with, or sell
substantially all of its assets to another corporation or entity, or shall
become a controlled subsidiary of a corporation (i.e. eighty per cent or more of
the outstanding common shares of stock of the Company has been acquired by such
other corporation), then the Consultants shall render the services provided for
under this Agreement to such other corporation or entity, provided that such
other corporation or entity shall assume this Agreement and shall perform all
the terms and conditions hereof on the part of the Company. In such event, the
Consultants' rights hereunder shall remain unimpaired and their obligations
shall continue in favor of such other corporation or entity. Subject to the
foregoing, the rights and obligations under this Agreement shall inure to the
benefit of, and shall be binding upon, the heirs, legatees, successors and
permitted assigns of the Consultants, and upon the successors and assigns of the
Company.

     

               6.           Default.

     

                          6.1.
In the event either of the Consultants commits any material violation of the
provisions of this Agreement, then, in addition to any other remedies which the
Company might have at law or in equity, the Company shall have the right to
set-off any actual and reasonable damages incurred by it against any payments
otherwise due hereunder. Nothing contained herein shall preclude the Company
from seeking damages or injunctive relief against the Consultants as provided in
Section 6.2.

     

                          6.2
In the event either of the Consultants commits any material violation of the
provisions of Section 2 of this Agreement, as determined by the Company in good
faith, the Company may, by injunctive action, compel the Consultants to comply
with, or restrain the Consultants from violating, such provision, and, in
addition, and not in the alternative, the Company shall be entitled to declare
the Consultants in default hereunder and to terminate any further payments
hereunder.

     

               7.         Severability and
Reformation. The parties hereto intend all provisions of this Agreement
to be enforced to the fullest extent permitted by law. If any restriction set
forth in Section 2 is held by a court of competent jurisdiction to be
unenforceable with respect to one or more geographic areas, lines of business
and/or months of duration, then Consultants agree, and hereby submit, to the
reduction and limitation of such restriction to the minimal extent necessary so
that the provisions of Section 2 shall be enforceable. If any other provision of
this Agreement is held to be illegal, invalid, or unenforceable under present or
future law, such provision shall be fully severable, and this Agreement shall be
construed and enforced as if such illegal, invalid or unenforceable provision
were never apart hereof, and the remaining provisions shall remain in full force
and shall not be affected by the illegal, invalid, or unenforceable provision,
or by its severance.

    

    
      
        
           

        

        
          - 7
-

          
            

          

        

        
           

        

      

    

     

               8.        Notices. Any notices
required by this Agreement shall (i) be made in writing and mailed by certified
mail, return receipt requested, with adequate postage prepaid, (ii) be deemed
given when so mailed, (iii) be deemed to be received by the addressee within ten
(10) days after given or when the certified mail receipt for such mail is
executed, whichever is earlier, and (iv) in the case of the Company, be mailed
to its principal office, or in the case of the Consultants, be mailed to the
last address that the Consultants have given to the Company.

     

               9.         WAIVER OF
JURY TRIAL.
THE PARTIES HEREBY
VOLUNTARILY AND INTENTIONALLY WAIVE ANY RIGHT THEY MAY HAVE TO A TRIAL BY JURY
IN ANY ACTION, PROCEEDING OR LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF,
UNDER OR IN CONNECTION WITH THIS AGREEMENT.

     

               10.      Miscellaneous.

     

                          10.1.
This Agreement may not be amended except by a written instrument signed and
delivered by the parties hereto.

     

                          10.2.
This Agreement, together with the Acquisition Agreement, constitute the
entire understanding between the parties hereto with respect to the subject
matter hereof, and all other agreements relating to the subject matter hereof
are hereby superseded.

     

                          10.3.
This Agreement shall be governed by, and construed in accordance with, the laws
of the Commonwealth of Pennsylvania.

     

                          10.4. The Company's Affiliates
are intended to be third-party beneficiaries of this Agreement, whether or not
parties hereto, and each of them shall have the right to enforce this Agreement
against the Consultants, whether or not the Company joins in such
action.

     

     

     

    [BALANCE
OF PAGE INTENTIONALLY LEFT BLANK]

     

     

    

     

    

    
      
        
           

        

        
          - 8
-

          
            

          

        

        
           

        

      

    

     

               IN
WITNESS WHEREOF, the parties have executed, under seal, this Consulting and
Non-Competition Agreement as of the day and year first above
written.

     

     

    

     

    
      
        
          
            
              
                
                  
                    
                      
                        
                          
                            
                              
                                
                                  
                                    
                                      
                                        
                                          
                                            	 
      	 /s/
      Robert O. Young 	 
      
	 
      	
                                                    Robert
      O. Young

                                                  	 
      
	 	 	 	 
	 	 	 	 
	 	 /s/
      Shelley R. Young 	 
	 
      	
                                                    Shelley
      R. Young

                                                  	 
      
	 	 	 	 
	 	 	 	 
	 
      	
                                                    DARIUS
      MARKETING. INC.

                                                  	 
      
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 
      	By:	
                                                     /s/ Ronald R. Howell, President 

                                                  	 
      
	 
      	
                                                    Ronald
      R. Howell, President

                                                  	 
      

                                          

                                        

                                      

                                    

                                  

                                

                              

                            

                          

                        

                      

                    

                  

                

              

            

          

        

      

    

    

     

    
      - 9
-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00158-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00158-of-00352.parquet"}]]